The sold production of vaccines for veterinary medicine in France saw growth from 2013 to 2018, with consistent year-on-year increases and a peak in 2018. Starting in 2019, there was a notable decline, and production fell sharply by 45.27%. This downward trend continued through 2020. However, a modest recovery began in 2021, and production values from 2022 onward have been relatively stable. As of 2023, the production stood at 306.66 million Euros. The five-year CAGR leading up to 2024 indicates a slight average decline in production.
Looking forward, the forecast suggests a very modest recovery, with expected yearly increases resulting in a forecasted value of 314.85 million Euros by 2028. The projected five-year CAGR is positive, but only marginally at 0.42%, indicating slow but steady growth.
Future trends to watch for include technological advancements in vaccine production, potential regulatory changes in the veterinary sector, and shifts in demand driven by livestock health needs and emerging diseases.
